Glowing blue energy surrounding a woman, symbolizing bladder health and treatment options.

Beyond Kegels: Exploring the Latest Advances in Women's Urological Health

Avery Sinclair monogram
Avery Sinclair in Health & Wellness November 2026 • 4 min read.

"From laser therapy skepticism to cellular regeneration: A deep dive into the evolving landscape of treating incontinence and bladder dysfunction."


Women's urological health is a dynamic field, constantly evolving with new research and treatment options. This article explores some of the most recent developments, controversies, and potential breakthroughs in the management of conditions like stress urinary incontinence (SUI) and overactive bladder (OAB).

We'll delve into the ongoing debate surrounding laser therapy for SUI and vaginal rejuvenation, examining the concerns raised by experts regarding its efficacy and the need for more rigorous clinical trials. We'll also explore promising research into bladder regeneration using wolffian duct epithelial cells, a potential game-changer for treating bladder damage.

Finally, we'll analyze data on the medical management of OAB and benign prostatic hyperplasia (BPH), uncovering surprising statistics about diagnosis rates and medication persistence. This information will empower you to make informed decisions about your urological health and advocate for the best possible care.

AI Search Multiple angles on this topic

How SUI Affects Quality of Life

Stress urinary incontinence (SUI) significantly affects quality of life, creating a need to explore treatment options beyond conventional approaches. The supplied source describes laser therapy as an area of interest, but provides no prevalence, patient-count, or other population statistics. Its snippet does not report evidence that establishes laser therapy’s effectiveness.

The Laser Therapy Debate: Hope vs. Hype?

Glowing blue energy surrounding a woman, symbolizing bladder health and treatment options.

Laser therapy for stress urinary incontinence (SUI) and vaginal rejuvenation has gained popularity in recent years. However, the medical community remains divided on its effectiveness and safety. A key point of contention is the lack of robust, randomized controlled trials to support its widespread use.

One study, which analyzed data from 818 patients undergoing laser therapy for SUI, found no randomized controlled trials and significant variability in laser systems, inclusion/exclusion criteria, and outcome measures. This led the authors to conclude that current evidence does not justify the routine use of vaginal laser therapy for SUI.

  • Limited Evidence: Current research is insufficient to support routine use.
  • Varied Approaches: Lack of standardization in laser systems and treatment protocols raises concerns.
  • Need for Trials: Randomized controlled trials are crucial to determine efficacy and safety.
AI Search Multiple angles on this topic

Trials and Reviews of Vaginal Laser Therapy

A single-blinded, multicenter randomized controlled trial evaluates vaginal Erbium:YAG laser treatment for SUI against sham treatment over 12 months. A 2023 systematic review describes vaginal laser therapy as a treatment being considered for SUI, which it identifies as the most common type of urinary incontinence in women. A 2025 review searched PubMed, Scopus, Web of Science, and Embase for studies published from January 1, 2014, through November 30, 2024, to assess laser therapy for SUI. The supplied summaries do not provide the trial’s results or enough detail to determine the reviews’ conclusions.

Evidence Limits and Uncertainty

The 2025 literature review searched for studies of laser therapy for SUI in PubMed and Scopus, among other databases, but the supplied abstract snippet does not state its findings. A separate 2025 systematic review and meta-analysis assessed randomized trials of vaginal lasers for SUI, but its supplied summary likewise gives no results. The available material therefore does not support a specific claim about whether laser treatment succeeds or fails, or how it compares with established approaches.

Er:YAG and CO₂ Laser Comparison

A retrospective study compared Er:YAG and CO₂ laser therapies for female SUI and included 139 women. The supplied results report that urinary incontinence symptoms improved from baseline in both groups at the one- and three-month follow-ups, with p < 0.001. These results describe improvement within both treatment groups; the supplied material does not establish that one laser type was more effective than the other.

Despite the skepticism, some studies have shown promising results, suggesting potential benefits for certain patients. However, experts emphasize the importance of proceeding with caution and only offering laser therapy within the setting of a clinical trial until more conclusive evidence is available.

Looking Ahead: The Future of Urological Care

The field of urology is constantly evolving, with ongoing research and development of new treatments for a variety of conditions. From regenerative medicine to personalized approaches to medication management, there is reason to be optimistic about the future of urological care.

AI Search Multiple angles on this topic

Personalized Care and Market Projections

A 2024 narrative review synthesizes current research and envisions emerging technologies supporting more personalized, patient-centered urinary incontinence care. Separately, a market outlook estimates the global laser-for-SUI market at USD 259 million in 2024 and projects it will reach USD 393 million by 2031, with a forecast CAGR of 6.3%. The market figures are projections, while the review describes a possible direction for future care.

Patient-Reported Effects in Clinical Settings

A study of Japanese women was the first to report on the effect of laser therapy on urinary incontinence. In a separate real-world service evaluation, nonablative Er:YAG laser treatment was associated with substantial, clinically meaningful improvements in patient-reported SUI-related quality of life. The evaluation supports the treatment’s use in clinical practice, but its authors note that the study design limits the strength of conclusions that can be drawn.

While laser therapy for SUI remains a topic of debate, other promising avenues are being explored, such as bladder regeneration using wolffian duct epithelial cells. This research could potentially revolutionize the treatment of bladder damage and dysfunction.

Ultimately, the key to optimal urological health is to stay informed, advocate for your needs, and work closely with your healthcare provider to develop a personalized treatment plan that addresses your specific concerns and goals.

Laser outcomes against sham and control groups

  • 0.0136At six months, the reported cure rate and primary outcome did not differ between the Er:YAG laser and sham groups; the reported cure rates were 0.0136 and 0.0000, respectively.[1]Caveat: There was no difference in the reported cure rate and the primary outcome.
  • 36%In a separate sham-controlled trial, treatment success was observed in 36% of the sham group and 59% of the active-treatment group; the reported odds ratio was 3.63.[2]

How the laser reports compare with other evidence

The Er:YAG sham-controlled trial followed adults with symptomatic SUI at a single tertiary hospital, with assessments at six weeks and six months. Its setting and follow-up describe the scope of that comparison, not outcomes across all care settings.[1]

Pelvic floor muscle training is described as exercise intended to improve pelvic floor muscle function and as a widely used treatment across stress, urgency, and mixed incontinence. This places it among established approaches discussed in the evidence, rather than making it a direct comparison with laser therapy.[3]

Approaches described for overactive bladder include medical therapy, bladder training, pelvic floor muscle exercises with or without biofeedback, and electrical stimulation. This is a separate set of management approaches from the laser comparisons for SUI.[4]

What remains unresolved in the SUI comparisons

  • Why do sham-controlled laser reports differ in whether they find a treatment advantage, and how much do their distinct outcomes and trial settings account for that difference?[1] [2]
  • How do the reported CO₂ laser results compare with pelvic floor muscle training when both are assessed under the same conditions and against the same comparator?[3] [5]
  • To what extent do regenerative responses in animal models correspond to outcomes in people with SUI?[6]

Sources

  1. Double-blind randomized controlled trial of Er: YAG vaginal laser to treat female stress urinary incontinence. (pubmed.ncbi.nlm.nih.gov)
  2. Vaginal erbium laser treatment for stress urinary incontinence: A multicenter randomized sham-controlled clinical trial. (pubmed.ncbi.nlm.nih.gov)
  3. Pelvic floor muscle training for urinary incontinence in women | Cochrane (www.cochrane.org)
  4. Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study (pmc.ncbi.nlm.nih.gov)
  5. Vaginal Laser Therapy for Stress Urinary Incontinence: A Systematic Review of Prospective Randomized Clinical Trials (pmc.ncbi.nlm.nih.gov)
  6. Cell Therapy in the Treatment of Female Stress Urinary Incontinence: Current Status and Future Proposals (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is stress urinary incontinence (SUI), and what does the article say about its treatment?

Stress urinary incontinence (SUI) is a condition where there is involuntary leakage of urine during physical activities like coughing, sneezing, or exercise. The article highlights the debate surrounding laser therapy for SUI, a treatment that has gained popularity but lacks sufficient evidence from robust, randomized controlled trials to support its widespread use. The implications are significant because the lack of standardized protocols and the variability in laser systems raise concerns about the reliability of the treatment's effectiveness and safety. The experts recommend caution and further clinical trials to ascertain its true value.

2

What is overactive bladder (OAB), and why is its medical management mentioned?

Overactive bladder (OAB) is a condition characterized by a frequent and sudden urge to urinate, which may or may not be accompanied by urge incontinence. The article touches upon the medical management of OAB, providing statistics about diagnosis rates and medication persistence, which can empower patients to make informed decisions about their health. The implications of managing OAB relate to patient quality of life, since this condition can be disruptive, embarrassing and even isolating.

3

What is bladder regeneration, and what is its significance?

Bladder regeneration is the process of repairing or regrowing damaged bladder tissue. The article references promising research into bladder regeneration using wolffian duct epithelial cells. This is significant because it represents a potential breakthrough in treating bladder damage, offering a new approach beyond current treatments. The implications are substantial as bladder regeneration could provide lasting solutions for individuals with bladder dysfunction, improving their overall health and well-being.

4

What is the medical community's view on laser therapy?

The medical community's stance on laser therapy for stress urinary incontinence (SUI) is one of cautious skepticism. Although the procedure has gained popularity, the current research lacks robust, randomized controlled trials. The article points out the variability in laser systems, treatment protocols, and outcome measures that raise concerns about the reliability and standardization of the procedures. The implications are that without rigorous testing, the long-term effectiveness and safety of laser therapy cannot be definitively established, necessitating further research.

5

What is the overall focus of the article regarding women's urological health?

The article discusses the dynamic nature of women's urological health, highlighting new research, treatments, and ongoing debates. It explores the current state of conditions such as stress urinary incontinence (SUI) and overactive bladder (OAB). The implications are that advances in this field have the potential to significantly improve the quality of life for women. Staying informed about the latest developments empowers individuals to make the best healthcare decisions and advocate for optimal care. The article discusses the current state of research, from laser therapy to the potential use of bladder regeneration.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.